Provident Trust Company’s AbbVie ABBV Stock Holding History

Provident Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.35M	Hold	10,787	–	–	0.05%	17
2025 Q4	$2.46M	Sell	10,787 -535	-5%	-$122K	0.04%	17
2025 Q3	$2.62M	Hold	11,322	–	–	0.04%	18
2025 Q2	$2.1M	Hold	11,322	–	–	0.04%	18
2025 Q1	$2.37M	Hold	11,322	–	–	0.04%	19
2024 Q4	$2.01M	Hold	11,322	–	–	0.03%	18
2024 Q3	$2.24M	Buy	11,322 +252	+2%	+$47K	0.04%	20
2024 Q2	$1.9M	Hold	11,070	–	–	0.04%	20
2024 Q1	$2.02M	Hold	11,070	–	–	0.04%	20
2023 Q4	$1.72M	Hold	11,070	–	–	0.04%	20
2023 Q3	$1.65M	Hold	11,070	–	–	0.04%	20
2023 Q2	$1.49M	Hold	11,070	–	–	0.03%	20
2023 Q1	$1.76M	Hold	11,070	–	–	0.05%	17
2022 Q4	$1.79M	Hold	11,070	–	–	0.05%	17
2022 Q3	$1.49M	Hold	11,070	–	–	0.04%	15
2022 Q2	$1.7M	Hold	11,070	–	–	0.04%	14
2022 Q1	$1.79M	Hold	11,070	–	–	0.04%	16
2021 Q4	$1.5M	Hold	11,070	–	–	0.03%	18
2021 Q3	$1.19M	Sell	11,070 -4,908	-31%	-$561K	0.02%	18
2021 Q2	$1.8M	Hold	15,978	–	–	0.04%	17
2021 Q1	$1.73M	Hold	15,978	–	–	0.04%	17
2020 Q4	$1.71M	Hold	15,978	–	–	0.04%	17
2020 Q3	$1.4M	Hold	15,978	–	–	0.04%	17
2020 Q2	$1.57M	Hold	15,978	–	–	0.05%	17
2020 Q1	$1.22M	Hold	15,978	–	–	0.05%	17
2019 Q4	$1.42M	Hold	15,978	–	–	0.04%	18
2019 Q3	$1.21M	Hold	15,978	–	–	0.04%	20
2019 Q2	$1.16M	Hold	15,978	–	–	0.04%	18
2019 Q1	$1.29M	Hold	15,978	–	–	0.05%	17
2018 Q4	$1.47M	Hold	15,978	–	–	0.06%	17
2018 Q3	$1.51M	Hold	15,978	–	–	0.05%	16
2018 Q2	$1.48M	Hold	15,978	–	–	0.05%	16
2018 Q1	$1.51M	Hold	15,978	–	–	0.06%	16
2017 Q4	$1.54M	Hold	15,978	–	–	0.06%	16
2017 Q3	$1.42M	Hold	15,978	–	–	0.06%	16
2017 Q2	$1.16M	Hold	15,978	–	–	0.06%	16
2017 Q1	$1.04M	Hold	15,978	–	–	0.05%	17
2016 Q4	$1M	Hold	15,978	–	–	0.05%	17
2016 Q3	$1.01M	Hold	15,978	–	–	0.06%	18
2016 Q2	$989K	Hold	15,978	–	–	0.05%	17
2016 Q1	$913K	Hold	15,978	–	–	0.05%	17
2015 Q4	$947K	Hold	15,978	–	–	0.05%	17
2015 Q3	$869K	Sell	15,978 -471	-3%	-$30.7K	0.05%	16
2015 Q2	$1.1M	Hold	16,449	–	–	0.06%	15
2015 Q1	$963K	Hold	16,449	–	–	0.06%	15
2014 Q4	$1.08M	Sell	16,449 -475	-3%	-$29.9K	0.06%	15
2014 Q3	$978K	Hold	16,924	–	–	0.06%	16
2014 Q2	$955K	Buy	+16,924	New	+$888K	0.05%	16

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Provident Trust Company's ABBV Position: Q1 2026 in Review

Provident Trust Company held its AbbVie (ABBV) position steady in Q1 2026 at 10,787 shares worth $2.35M. The position accounts for 0.05% of the portfolio, ranked #17.

Provident Trust Company first reported a position in ABBV in Q2 2014 and has held it in 48 quarters since. The position peaked at $2.62M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Provident Trust Company held 10,787 shares of AbbVie worth $2.35M as of Q1 2026.
Provident Trust Company left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.05% of Provident Trust Company's portfolio in Q1 2026, its #17 holding.
Provident Trust Company first reported a position in AbbVie in Q2 2014 and has held it in 48 quarters since.
Provident Trust Company's AbbVie position peaked at $2.62M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Provident Trust Company's 13F filing for Q1 2026, filed 27 Apr 2026.